Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

Motoya, Satoshi; Watanabe, Kenji; Ogata, Haruhiko; Kanai, Takanori; Matsui, Toshiyuki; Suzuki, Yasuo; Shikamura, Mitsuhiro; Sugiura, Kenkichi et al. · PLoS One · 2019

rct · Level II

Where this comes from

Record sourced from PubMed, PMID 30973957.
Also identified by DOI 10.1371/journal.pone.0215491 and PMC identifier 6459474.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0212989.].

Read the full text

View on PubMed · Publisher (DOI)